Display options
Share it on

FEBS Open Bio. 2015 Jun 12;5:522-7. doi: 10.1016/j.fob.2015.06.003. eCollection 2015.

Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice.

FEBS open bio

Tsukasa Tominari, Chiho Matsumoto, Kenta Watanabe, Michiko Hirata, Florian M W Grundler, Chisato Miyaura, Masaki Inada

Affiliations

  1. Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan ; Global Innovation Research Organization, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan.
  2. Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei, Tokyo 184-8588, Japan.
  3. Institute of Crop Science and Resource Conservation, University of Bonn, Karlrobert-Kreiten-Strasse 13, 53115 Bonn, Germany.

PMID: 26155460 PMCID: PMC4491591 DOI: 10.1016/j.fob.2015.06.003

Abstract

Epigallocatechin gallate (EGCG), a major polyphenol in green tea, possesses antioxidant properties and regulates various cell functions. Here, we examined the function of EGCG in inflammatory bone resorption. In calvarial organ cultures, lipopolysaccharide (LPS)-induced bone resorption was clearly suppressed by EGCG. In osteoblasts, EGCG suppressed the LPS-induced expression of COX-2 and mPGES-1 mRNAs, as well as prostaglandin E2 production, and also suppressed RANKL expression, which is essential for osteoclast differentiation. LPS-induced bone resorption of mandibular alveolar bones was attenuated by EGCG in vitro, and the loss of mouse alveolar bone mass was inhibited by the catechin in vivo.

Keywords: BMN, bone mineral density; Bone resorption; COX, cyclo-oxygenase; EGCG, (−)-epigallocatechin-3-gallate; Epigallocatechin gallate; LPS, lipopolysaccharide; Lipopolysaccharide; OCPC, o-cresolphthalein complexon; OPG, osteoprotegerin; Osteoblasts; PGE2, prostaglandin E2; PSD, polymicrobial synergy and dysbiosis; Periodontitis; Prostaglandin E; RANKL, receptor activator of NF-kB ligand; mPGES, membrane-bound PGE synthase

References

  1. Nat Immunol. 2010 May;11(5):373-84 - PubMed
  2. J Periodontal Res. 2014 Oct;49(5):652-9 - PubMed
  3. J Pharmacol Sci. 2012;119(4):390-4 - PubMed
  4. Gynecol Endocrinol. 2013 Aug;29(8):735-43 - PubMed
  5. J Biol Chem. 2000 Jun 30;275(26):19819-23 - PubMed
  6. Cell Tissue Res. 2014 May;356(2):381-90 - PubMed
  7. J Periodontol. 2008 May;79(5):920-8 - PubMed
  8. Nature. 1997 Nov 13;390(6656):175-9 - PubMed
  9. Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):88-99 - PubMed
  10. Biochem Biophys Res Commun. 2009 Feb 20;379(4):1033-7 - PubMed
  11. Cell. 1998 Apr 17;93(2):165-76 - PubMed
  12. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602 - PubMed
  13. J Biol Chem. 2000 Oct 20;275(42):32783-92 - PubMed
  14. J Periodontal Res. 2013 Dec;48(6):781-9 - PubMed
  15. J Immunol. 2006 Aug 1;177(3):1879-85 - PubMed
  16. Annu Rev Pharmacol Toxicol. 2002;42:25-54 - PubMed
  17. J Nutr Biochem. 2007 May;18(5):341-7 - PubMed
  18. Biochem Biophys Res Commun. 2012 Nov 9;428(1):110-5 - PubMed
  19. Mol Oral Microbiol. 2012 Dec;27(6):409-19 - PubMed
  20. Free Radic Res Commun. 1987;2(4-6):289-94 - PubMed
  21. Endocr Rev. 1999 Jun;20(3):345-57 - PubMed

Publication Types